Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$57.92 - $72.58 $380,244 - $476,487
-6,565 Closed
0 $0
Q4 2021

Jan 12, 2022

SELL
$64.88 - $73.64 $167,844 - $190,506
-2,587 Reduced 28.27%
6,565 $477,000
Q3 2021

Oct 12, 2021

SELL
$67.69 - $73.03 $424,822 - $458,336
-6,276 Reduced 40.68%
9,152 $639,000
Q2 2021

Jul 13, 2021

SELL
$63.47 - $69.35 $655,581 - $716,316
-10,329 Reduced 40.1%
15,428 $1.06 Million
Q1 2021

Apr 13, 2021

BUY
$60.0 - $68.46 $179,340 - $204,626
2,989 Added 13.13%
25,757 $1.67 Million
Q4 2020

Jan 12, 2021

SELL
$56.65 - $64.55 $302,850 - $345,084
-5,346 Reduced 19.02%
22,768 $1.33 Million
Q3 2020

Oct 09, 2020

SELL
$62.1 - $78.08 $5,589 - $7,027
-90 Reduced 0.32%
28,114 $1.78 Million
Q2 2020

Jul 08, 2020

SELL
$72.34 - $84.0 $78,633 - $91,308
-1,087 Reduced 3.71%
28,204 $2.17 Million
Q1 2020

Apr 08, 2020

BUY
$62.63 - $80.22 $116,930 - $149,770
1,867 Added 6.81%
29,291 $2.19 Million
Q4 2019

Jan 13, 2020

BUY
$61.62 - $67.78 $266,013 - $292,606
4,317 Added 18.68%
27,424 $1.78 Million
Q3 2019

Oct 11, 2019

BUY
$62.51 - $69.0 $295,922 - $326,646
4,734 Added 25.77%
23,107 $1.47 Million
Q2 2019

Jul 12, 2019

BUY
$61.87 - $69.38 $171,627 - $192,460
2,774 Added 17.78%
18,373 $1.24 Million
Q1 2019

Apr 11, 2019

SELL
$62.53 - $70.05 $733,164 - $821,336
-11,725 Reduced 42.91%
15,599 $1.01 Million
Q4 2018

Jan 16, 2019

BUY
$60.54 - $79.0 $1.03 Million - $1.34 Million
16,990 Added 164.41%
27,324 $1.71 Million
Q3 2018

Oct 11, 2018

BUY
$71.28 - $78.92 $271,220 - $300,290
3,805 Added 58.28%
10,334 $798,000
Q2 2018

Jul 13, 2018

BUY
$64.88 - $75.68 $112,501 - $131,229
1,734 Added 36.16%
6,529 $463,000
Q1 2018

Apr 16, 2018

BUY
$72.84 - $88.8 $349,267 - $425,796
4,795 New
4,795 $361,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Town & Country Bank & Trust CO Dba First Bankers Trust CO Portfolio

Follow Town & Country Bank & Trust CO Dba First Bankers Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Town & Country Bank & Trust CO Dba First Bankers Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Town & Country Bank & Trust CO Dba First Bankers Trust CO with notifications on news.